Skip to content

Viatris VTRS EV / EBITDA

EV / EBITDA at other companies

Pfizer logo
PfizerPFE
12.9×
McKesson logo
McKessonMCK
16.1×-2.6×
Cencora logo
CencoraCOR
18.6×+2.4×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
21.5×-1.1×
Roivant Sciences logo
Roivant SciencesROIV
1.8×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
16.4×-5.2×

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.32B+49.6%
Enterprise value$31.13B+17.7%
P/S1.3×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

Based on the most recent quarter.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's EV / EBITDA?
Viatris (VTRS) reported EV / EBITDA of 9.6× in Q1 2026.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.